Question 1
After HSCT, a patient exhibits restlessness, pacing, and nail biting. The nurse anticipates an order for which type of medication?
Correct Answer:
Benzodiazepine
Explanation:
Anxiety-driven agitation is being depicted here. A benzodiazepine is the best choice because it quickly calms the nervous system by enhancing GABA activity, which reduces restlessness, pacing, and compulsive behaviors like nail biting. This provides rapid, short-term relief of acute agitation in a hospitalized patient, including after HSCT, and helps the patient settle so further assessment and care can proceed. Donepezil is for cognitive decline and won’t address acute anxiety or agitation. Corticosteroids can cause mood and behavioral changes but aren’t used primarily to treat agitation. Neuroleptics can help with severe agitation or delirium with psychosis, but they carry more risks (like extrapyramidal symptoms and sedation) and are not first-line for simple anxiety-driven restlessness.
Question 2
When calculating calcineurin inhibitor dosing in HSCT patients on voriconazole, what is recommended?
Correct Answer:
Give drugs at least four hours apart, reduce CNI by 1/3-1/4, and monitor levels closely
Explanation:
Voriconazole strongly inhibits the enzyme that metabolizes calcineurin inhibitors (like tacrolimus or cyclosporine), so coadministration can cause CNI levels to rise dramatically and risk serious toxicity. To manage this, the best approach is to significantly cut the CNI dose and monitor levels closely, while also staggering administration times to lessen any peak interaction. Reducing the CNI to about one-third to one-quarter of the original dose and giving the CNI and voriconazole at least four hours apart provides the most reliable way to maintain immunosuppression without toxicity, with therapeutic drug monitoring guiding further adjustments. If intolerance or toxicity occurs despite these measures, switching voriconazole could be considered, but the standard recommendation is dose reduction plus monitoring with timing adjustments.
Question 3
Which graft source is more likely to develop acute graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation?
Correct Answer:
Peripheral blood stem cells
Explanation:
Acute GVHD risk primarily follows the number of mature donor T cells present in the graft. Peripheral blood stem cell grafts contain more mature T cells than bone marrow or umbilical cord blood, so they are more likely to mount an alloimmune response against the host after transplant. Umbilical cord blood has primarily naive T cells and lower immediate allo-reactivity, which lowers acute GVHD risk despite slower engraftment. Bone marrow grafts have fewer mature T cells than peripheral blood but more than cord blood, giving an intermediate risk. Therefore, the graft source most likely to develop acute GVHD is peripheral blood stem cells.
Question 4
Which portion of the immunoglobulin activates the complement pathway?
Correct Answer:
Fc
Explanation:
Complement activation via the classical pathway starts when the C1 complex binds to the Fc portion of an antibody that is attached to its antigen. The Fc region is the constant part of the antibody heavy chains; it’s this region that interacts with C1 to kick off the cascade. The Fab regions are the antigen-binding sites, so they bind the target but don’t trigger complement on their own. MHC Class I and II are involved in presenting peptides to T cells, not in activating the antibody-driven complement pathway. Notably, IgM can activate complement efficiently because its pentameric form presents multiple Fc sites for C1 binding.
Question 5
Which of the following is a nursing intervention for long-term survivors?
Correct Answer:
All of the above
Explanation:
Long-term survivors benefit from nursing strategies that promote ongoing self-care, psychosocial reintegration, and active engagement in health. Instructing female patients to perform monthly breast self-exams and male patients to perform testicular self-exams supports ongoing personal health monitoring, helping patients detect changes early and stay engaged with their overall wellness as they move forward from treatment. Providing information to patients and families on school reentry programs addresses the need for social and educational reintegration. Returning to school can be challenging after intense therapy, and having tailored information helps families plan accommodations, manage fatigue or cognitive late effects, and maintain continuity in education and peer relationships, which is vital for quality of life. Encouraging patients to understand their disease and past treatments empowers them to take an active role in their future health and well-being. Health literacy and engagement lead to better adherence to follow-up care, timely reporting of late effects, informed decision-making, and proactive lifestyle choices that support long-term survivorship. Together, these interventions cover physical monitoring, psychosocial adjustment, and empowered self-management, making this a comprehensive and effective approach for long-term survivors.
Question 1
Exam overview

About this Exam

The Blood & Marrow Transplant Certified Nurse (BMTCN®) certification validates your specialized knowledge and expertise in the rapidly evolving field of hematopoietic cell transplantation. This prestigious credential, offered by the Oncology Nursing Certification Corporation (ONCC), is designed specifically for registered nurses (RNs) who have dedicated their practice to caring for patients undergoing blood and marrow transplants. Achieving BMTCN® status demonstrates your commitment to providing the highest standard of care and your mastery of the complex physiological, psychosocial, and ethical challenges associated with this life-saving therapy.

More details

Additional Information

What the Course Entails and Exam Details

The BMTCN® certification is not just about testing your memory; it’s about validating your ability to apply complex knowledge to real-world clinical scenarios. The exam content is meticulously tailored to the scope and standards of current BMT nursing practice.

You will need to demonstrate proficiency in six major subject areas, weighted as follows in the overall exam score:

  • Basic Concepts and Indications for Transplantation (10%): Understanding hematopoiesis, immunology, and the rationale behind choosing transplant as a treatment.

  • Types of Transplants and Sources of Stem Cells (8%): Differentiating between autologous, allogeneic, and synergistic transplants, and understanding the nuances of bone marrow, peripheral blood, and umbilical cord stem cell sources.

  • Pre-Transplant Care (10%): Covering recipient and donor evaluation, education, and preparative regimen planning.

  • Preparative Regimens and Stem Cell Infusion (15%): Specifics on conditioning therapies (chemotherapy, radiation, biotherapy) and the actual process of cell infusion and management.

  • Graft-Versus-Host Disease (GVHD) Prevention and Management (15%): Acute and chronic GVHD pathophysiology, presentation, grading, and intervention strategies.

  • Post-Transplant Issues (26%): The largest section, focusing on early and late complications, infection control, system-specific challenges, engraftment, and disease relapse.

  • Survivorship Issues (8%): Addressing long-term quality of life, secondary malignancies, fertility, and follow-up care protocols.

  • Professional Practice (8%): Ethical and legal concepts, data sources, continuous quality improvement, and scope and standards of practice.


What to Expect in the Final Exam

When you arrive at the testing center (or log into your online proctoring session), you should be prepared for a rigorous but fair comprehensive assessment.

  • Format: The BMTCN® exam consists of 165 multiple-choice questions. Only 145 of these questions are scored, while 20 are unmarked, unscored pretest questions being evaluated for future exams. You will not know which questions are which, so answer every question to the best of your ability.

  • Time Limit: You are allocated exactly three hours (180 minutes) to complete the examination. There are no scheduled breaks; if you choose to take a break, your test time will continue to countdown.

  • Generic Drug Names: It is crucial to note that ONCC uses generic drug names throughout the exam, not brand names. Make sure your study regimen incorporates this.

  • Passing Score: ONCC uses a scaled score model to ensure fairness across different test forms. A raw score is converted to a scaled score ranging from 25 to 75. A scaled score of 55 or higher is required to pass.

  • Final Rules: No food, drink, reference materials, or electronic devices are permitted in the testing room. You must provide two valid forms of signature-bearing identification, one of which must include your photograph.


How to Study and Exam Centers

Effective preparation is the single biggest factor in your exam success.

  • Leverage the Test Content Outline: This is your primary blueprint. Use the percentages assigned to each domain to allocate your study time appropriately. Focus your initial efforts on the weightiest sections, such as "Post-Transplant Issues" and "GVHD Management."

  • Use Multiple Resources: The exam is not based on a single book. Utilize the official ONCC reference list, which includes core BMT textbooks, relevant standards from FACT (Foundation for the Accreditation of Cellular Therapy), and clinical practice guidelines from ONS (Oncology Nursing Society) and ASTCT (American Society for Transplantation and Cellular Therapy).

  • Incorporate Practice Exams: Take advantage of both the free 50-question and the paid 100-question practice tests offered by ONCC. These provide insight into the style of questions and help you manage your pacing.

  • Study Generic Drug Names: Create flashcards or lists matching brand names to generic equivalents for conditioning regimens, GVHD therapies, anti-infectives, and supportive care medications.

  • How to Take the Exam: The BMTCN® exam is administered by PSI Services, a leading global provider of assessment services. Once you receive your Authorization to Test (ATT) email, you can schedule your exam window (typically a 90-day period).

You can choose to take the exam at a physical PSI testing center, which are located throughout the United States and internationally. Alternatively, ONCC often offers the option of live remote proctoring, allowing you to take the exam on your own compatible computer in a secure, private location. Ensure you run a system compatibility check if choosing the online option.


Job Opportunities from the Course

Becoming BMTCN® certified instantly distinguishes you as an expert in your field and opens doors to advanced career paths and leadership opportunities. Employers recognize the credential as a symbol of validated skill and a commitment to safe, high-quality patient care.

Earning your BMTCN® designation unlocks positions such as:

  • BMT Staff Nurse (Inpatient or Outpatient)

  • Transplant Coordinator

  • Apheresis Nurse

  • CAR-T/Cellular Therapy Nurse

  • BMT Clinical Nurse Specialist

  • Nursing Case Manager (Transplant)

  • BMT Clinical Research Nurse

  • Quality Improvement Coordinator (Transplant)

  • Clinical Nurse Educator (Oncology/BMT)

  • BMT Unit Manager or Director

This certification provides the validation you need to excel in the most challenging and rewarding environments of blood and marrow transplantation. Good luck with your studies!


Quiz information

Frequently Asked Questions

The complete question count is available after full access is unlocked.
No fixed duration is currently configured for this quiz.
Question explanations are included where they are available in the quiz content, helping you review the reasoning after answering.
Yes. You can retake the practice test again as you continue studying during your available access period.
After your access is confirmed, you can continue into the complete practice exam from this quiz flow.
Unless explicitly stated otherwise, this page provides independent practice material for study and exam preparation and is not the official examination itself.
Keep studying

Related Questions